May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Preliminary In Vivo Analysis of CRALBP Transcriptional Regulation
Author Affiliations & Notes
  • B.N. Kennedy
    Pharmacology, University College Dublin, Dublin, Ireland
  • S.K. Bhattacharya
    Ophthalmic Research, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, OH
  • J.S. Crabb
    Ophthalmic Research, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, OH
  • V.L. Bonilha
    Ophthalmic Research, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, OH
  • J.W. Crabb
    Ophthalmic Research, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, OH
  • Footnotes
    Commercial Relationships  B.N. Kennedy, None; S.K. Bhattacharya, None; J.S. Crabb, None; V.L. Bonilha, None; J.W. Crabb, None.
  • Footnotes
    Support  NIH grants EY06603, EY14239, The Foundation Fighting Blindness and funds from the Cleveland Clinic F
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1261. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B.N. Kennedy, S.K. Bhattacharya, J.S. Crabb, V.L. Bonilha, J.W. Crabb; Preliminary In Vivo Analysis of CRALBP Transcriptional Regulation . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1261.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:In RPE, Cellular retinaldehyde binding protein (CRALBP) serves in the visual cycle as an 11–cis–retinol acceptor and as a substrate carrier. CRALBP is also expressed in Müller cells, ciliary epithelium, iris, cornea, pineal, brain and optic nerve. Toward deciphering the mechanisms controlling cell–specific expression of CRALBP, transgenic mice carrying mouse CRALBP promoter constructs have been generated and analyzed. Methods:Transgenic mice in strain B6CBA were generated in the Cleveland Clinic Transgenic Mouse Facility with EGFP reporter constructs containing either ∼1.4 Kb or ∼4.7 Kb of promoter from Rlbp1, the mouse gene encoding CRALBP. Southern blot and PCR were used for analysis of transgene expression. Founders were bred with mouse strains Balb/CbyJ or CD–1. Cryo sections of eye and brain tissues were processed for immunohistochemistry which was performed with antibodies to EGFP (BD Biosciences), GFAP (Sigma) and CRALBP. Nuclei were stained with TO–PRO–3 (Molecular Probes Inc). Results: Three independent founder mice were obtained for the 4.7Rlbp1–EGFP construct and two founders were obtained for the 1.4Rlbp1–EGFP construct. Breeding has yielded numerous progeny carrying the 4.7 Kb construct. Immunohistochemical analysis with anti–EGFP revealed GFP positive cells in the RPE and Müller cells of mice carrying the 4.7Rlbp1–EGFP construct. Concomitant labeling with CRALBP antibody was observed for many cells that showed expression of GFP or GFAP. Conclusions:The mouse CRALBP promoter region extending upstream from the transcription start site ∼4.7 Kb appears to direct expression to the RPE and Müller cells of the neural retina. Progress in on going histological analyses will be presented.

Keywords: gene/expression • retinoids/retinoid binding proteins • transgenics/knock–outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×